Pharmacokinetic–pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature

References

• Danhof M, de Jonghe J, deLange ECM, della Pasqua O, Ploeger BA, Voskuyl RA. Mechanism-based pharmacokinetic–pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. Annu. Rev. Pharmacol. Toxicol.47, 357–400 (2007).
   PubMed Web of Science ®Google Scholar
• Minto CF, Schnider TW. Contributions of PK/PD modeling to intravenous anesthesia. Clin. Pharmacol. Ther.84, 37–38 (2008).
   Google Scholar
• Segre G. Kinetics of interaction between drugs and biological systems. Farmaco. Sci.23(10), 907–918 (1968).
   PubMedGoogle Scholar
• Hull CJ. Pharmacokinetics and pharmacodynamic. Br. J. Anaesth.51, 579–594 (1979).
   Google Scholar
• Sheiner L, Stanski LB, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther.25, 358–371 (1979).
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Romberg R et al. Mechanism-based PK–PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin. Pharmacol. Ther.81, 50–58 (2007).
   PubMed Web of Science ®Google Scholar
• Miller R. Population pharmacokinetics. In: Principles of Clinical Pharmacology. Atkinson AJ, Daniels CE, Dedrick RL, Grudzinakis CV, Markey SP (Eds). Academic Press, CA, USA, 113–119 (2001).
   Google Scholar
• Heeremans EH, Proost JH, Eleveld DJ, Absalom AR, Struys MM. Population pharmacokinetics and pharmacodynamics in anesthesia, intensive care and pain medicine. Curr. Opion. Anaesthesiol.23, 479–484 (2010).
   Google Scholar
• Beal BL, Sheiner LB, Boeckman AJ, Bauer RJ. NONMEM User’s Guide. Icon Development Solutions, MD, USA (1989–2009).
   Google Scholar
• Shafer SL, Struys MMRF. Mixed effect modeling in analgesia trials. Anesth. Analg.107(1), 9–10 (2008).
   Google Scholar
• Bekkering GE, Soares-Weiser K, Reid K et al. Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Curr. Med. Res. Opin.27(7), 1477–1491 (2011).
   PubMed Web of Science ®Google Scholar
• Lötsch J. Pharmacokinetic–pharmacodynamic modeling of opioids. J. Pain Sympt. Manag.29(5 Suppl.), S90–S103 (2005).
   PubMed Web of Science ®Google Scholar
• Sarton E, Olofsen E, Romberg R et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology93, 1245–1254 (2000).
   PubMed Web of Science ®Google Scholar
• Niesters M, Dahan A, Kest B et al. Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies. Pain151, 61–68 (2010).
   PubMed Web of Science ®Google Scholar
• Dahan A, van Dorp E, Smith TW, Yassen A. Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur. J. Pain12, 403–411 (2008).
   PubMed Web of Science ®Google Scholar
• Romberg R, Olofsen E, Sarton E, den Hartigh J, Taschner PE, Dahan A. Pharmacokinetic–pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences. Anesthesiology100, 120–133 (2004).
   PubMed Web of Science ®Google Scholar
• Olofsen E, van Dorp E, Teppema L et al. Naloxone reversal of morphine- and morphione-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic–pharmacodynamic modeling study. Anesthesiology112, 1417–1427 (2010).
   PubMed Web of Science ®Google Scholar
• Garfield E. Current Comments: The 1982 John Scott Award goes to Jack Fishman and Harold Blumberg for synthesis and investigation of naloxone. Essays of an Information Scientist6, 121–130 (1983).
   Google Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology112(1), 226–238 (2010).
   PubMed Web of Science ®Google Scholar
• Mazoit JX, Butscher K, Samii K. Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites. Anesth. Analg.105(1), 70–78 (2007).
   PubMed Web of Science ®Google Scholar
• Abou Hammoud H, Simon N, Urien S, Riou B, Lechat P, Aubrun F. Intravenous morphine titration in immediate postoperative pain management: population kinetic–pharmacodynamic and logistic regression analysis. Pain144, 139–146 (2009).
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Kan J, Dahan A, Danhof M. Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine. Clin. Pharmacokinet.46(5), 433–447 (2007).
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Romberg R et al. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin. Pharmacol. Ther.81, 50–58 (2007).
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Romberg R, Sarton E, Danhof M, Dahan A. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology104, 1232–1242 (2006).
   PubMed Web of Science ®Google Scholar
• Noppers I, Niesters M, Aarts L, Smith T, Sraton E, Dahan A. Ketamine for treatment of chonic non-cancer pain. Expert Opin. Pharmacother.11(14), 2417–2429 (2010).
   PubMed Web of Science ®Google Scholar
• Herd DW, Anderson BK, Keene NA, Holford NK. Investigating pharmacodynamics of ketamine in children. Paediatr. Anaesth.18(1), 36–42 (2008).
   PubMed Web of Science ®Google Scholar
• Herd DW, Anderson BK, Holford NK. Modeling the norketamine metabolite in children and the implications for analgesia. Paediatr. Anesth.17(9), 831–840 (2007).
   PubMed Web of Science ®Google Scholar
• Sigtermans M, Dahan A, Mooren R et al.S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic–pharmacodynamic modeling study in healthy volunteers. Anesthesiology111, 892–903 (2009).
   PubMed Web of Science ®Google Scholar
• Kowalski KG, Olson S, Remmers AE, Hutmacher MM. Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain. Clin. Pharmacol. Ther.83, 857–866 (2008).
   PubMed Web of Science ®Google Scholar
• Li H, Mandema J, Wada R et al. Modeling the onset and offset of dental pain relief by ibuprofen. J. Clin. Pharmacol. DOI: 10.1177/0091270010389470 (2011) (Epub ahead of print).
   Google Scholar
• Green B, Chandler S, MacDonald G, Elliott G, Roberts MS. Quantifying pain relief following administration of a novel formulation of paracetamol (acetaminophen). J. Clin. Pharmacol.50, 1406–1413 (2010).
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Holford NH, Woollard GA, Kanagasundaram S, Mahadevan M. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology90(2), 411–421 (1999).
   PubMed Web of Science ®Google Scholar
• Olofsen E, Burm AG, Simon MJ, Veering BT, van Kleef JW, Dahan A. Population pharmacokinetic–pharmacodynamic modeling of epidural anesthesia. Anesthesiology109(4), 664–674 (2008).
   Google Scholar
• Dahan A, Olofsen E, Sigtermans M et al. Population pharmacokinetic–pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur. J. Pain5(3), 258–267 (2011).
   Google Scholar
• Byon W, Ouellet D, Chew M et al. Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change. J. Clin. Pharmacol.50, 803–815 (2010).
   PubMed Web of Science ®Google Scholar
• Sheiner LB. A new approach to the analysis of analgesic drug trials illustrated with bromfenac data. Clin. Pharmacol. Ther.56(3), 309–322 (1994).
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Kan J, Dahan A, Danhof M. Pharmacokinetic–pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats. Pharm. Res.25(1), 183–193 (2008).
   PubMed Web of Science ®Google Scholar
• Okie S. A flood of opioids, a rising tide of deaths. N. Eng. J. Med.363(21), 1981–1983 (2010).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Dunn KM. Chronic pain reconsidered. Pain138, 267–276 (2008).
   PubMed Web of Science ®Google Scholar
• Abandanes S, van der Aart J, Barletta JA et al. Prediction of repeat-dose occupancy from single-dose data: characteristics of the relationship between plasma pharmacokinetics and brain target occupancy. J. Cereb. Blood Flow Metab.31, 944–952 (2011).
   Google Scholar